Related by context. All words. (Click for frequent words.) 62 liver resection surgeries 59 Receives CE Marking 59 Expanded Indication 58 Investigational Device Exemption 57 Obtains CE Mark 57 Granted Orphan Drug 57 Accelerated Approval 57 Alair System 57 Premarket Approval PMA 56 PMA Supplement 56 received CE Conformite 56 CryoSeal FS System 56 Receives Orphan Drug Designation 56 Fast Track Status 56 Resubmission 56 Orphan Designation 56 Clinical Trial Evaluating 55 granted Ortec 55 Taro Receives 55 BioGlue R 55 Receives Marketing Authorization 55 Receives Orphan Drug 55 FDA Accepts 54 Premarket Approval 54 Orphan Status 54 Receives CE 54 GTC recombinant form 54 Angiox ® 54 Expedited Review 54 Recommends Approval 54 FDA Approvals 54 exemption IDE 54 Receives Approvable Letter 54 Files IND 54 Subpart E 54 k Clearance 54 Submits NDA 54 IND Filing 54 PROVENGE ® 53 Pivotal Clinical Trial 53 Receives Conditional 53 Submits Response 53 k Premarket Notification 53 Receives Fast Track 53 Trobalt 53 Files Investigational 53 Proposed Rule Changes 53 PDUFA Date 53 ENLIGHT 53 Accelerated Assessment 52 NexMed Receives 52 IDE Investigational Device Exemption 52 NYSE Amex Listing 52 Conditional Approval 52 Receives Approval From 52 Receives Positive Opinion 52 Approvable 52 Pivotal Study 52 Meets Primary Endpoint 52 IND Application 52 Psoriasis Drug 52 Market Approval PMA 51 Alexion Soliris 51 Complies With 51 Testosterone Gel 51 Favorable Ruling 51 Conformite Europeenne CE 51 Submits Application 51 ORBIT II 51 Receives Complete Response 51 Grants Orphan Drug 51 Positive Opinion 51 Receives Favorable 51 Unanimously Recommends 51 Inhaled Insulin 51 Orphan Drug designations 51 Esbriet ® 51 FDA Approvable Letter 51 Marketing Authorisation Application 51 FIRAZYR 51 Supplemental Biologics License Application 51 Orphan Drug status 51 Complies 51 CE Marking 51 Announces Tentative Approval 51 Receives Clearance 51 Recurrent Prostate Cancer 51 Esbriet pirfenidone 51 PMA submission 50 NDA Submission 50 Pivotal Phase III 50 ANDA Filing 50 PROMUS Element Stent System 50 Submits Supplemental 50 FDA Clearance 50 GRAS Status 50 Risperidone Oral Solution 50 Obtains FDA 50 Orphan Drug designation 50 Application MAA 50 Nabi HB Intravenous 50 Biologic License Application BLA 50 Genzyme Myozyme 50 Seasonal Influenza Vaccine 50 sNDA submission 50 Marketing Authorisation 50 Nivestim 50 Visa PED 50 Fast Track designations 50 Melody Transcatheter Pulmonary Valve 50 OMP designation 50 ComfortScan system 50 UCB Keppra 49 Barr ANDA 49 Permanent Injunction Against 49 sNDAs 49 Proxy Proposals 49 Generic Versions 49 Cintredekin besudotox 49 Use Authorization 49 Miraculins Announces 49 Intravenous Formulation 49 Arzerra TM 49 Receives Regulatory 49 Generic Version 49 SURFAXIN 49 Biophan patent 49 Medicure Announces 49 Becomes Effective 49 Lawsuit Challenging 49 CONBRIZA 49 Submits Investigational 49 Thalidomide Pharmion 49 Submits Biologics License Application 49 Listing Compliance 49 Preliminary Injunction Against 49 Testosterone Patch 49 Entocort 49 Phase III Clinical Trial 49 Dual Listing 49 Patient Enrollment 49 OMAPRO ™ 49 Issues Guidance 49 Product Designation 49 FDA Approval 48 include Naglazyme 48 Receives Tentative FDA 48 NerPharMa 48 synthetic lipoglycopeptide antibiotic 48 Ranolazine 48 Obtains Regulatory 48 balsalazide tablet 48 FDA Orphan Drug 48 Australian Therapeutic Goods 48 suburban St.Louis 48 Final Approval 48 FDA Panel Recommends 48 Humanitarian Device Exemption 48 #k Clearance 48 IV acetaminophen 48 Poniard Pharmaceuticals Announces 48 orphan designation 48 CIP TRAMADOL ER 48 CCHIT Certification 48 Asthma Inhaler 48 BioSante Pharmaceuticals Announces 48 Fast Track Designation 48 Panel Mulls 48 Lambert Eaton Myasthenic 48 Orphan Drug Status 48 vinorelbine emulsion 48 Spectrum Pharmaceuticals Announces 48 STERIS Corporation Announces 48 Patent Covering 48 Aloxi Injection 48 Scientific Advice 48 cytokine immunomodulator 48 Prostate Cancer Vaccine 47 Directorate TPD 47 Applauds Introduction 47 Recommends Changes 47 SJ Res 47 Silicone Breast Implants 47 Confirms Receipt 47 Subpart H 47 FDA Okays 47 Unsolicited Proposal From 47 successfully commercialize Iluvien 47 Issues Clarification 47 Announce Shareholder Approval 47 Troxatyl TM 47 Lawsuit Involving 47 Order Granting 47 Issues Complete Response 47 FIPS #-# certification 47 Conditional Listing 47 Exclusive License 47 Fast Tracked 47 HeartWare System 47 Ephedra Ban 47 Adjuvant Treatment 47 DORIBAX 47 Triage Stroke Panel 47 5 lipoxygenase inhibitor 47 Patent Reexamination 47 Marketing Authorization 47 PDL BioPharma Announces 47 Menaflex implant 47 Cellegesic 47 Obtains Approval 47 Firdapse ™ amifampridine phosphate 47 Announce Receipt 47 Receives Initial 47 Naglazyme ® galsulfase 47 Stockholder Approval 46 Emezine 46 Successful Completion 46 Diamyd Medical Diamyd 46 ISO #:# Certification [001] 46 PTCRB certification 46 Resubmits 46 Phase III Trial 46 Panel Considers 46 Mutual Recognition Procedure 46 mesylate tablets approved 46 Marketing Approval PMA 46 Approve Merger 46 Namenda XR 46 User Fee Act 46 Receives Confirmation 46 Regulatory Approvals 46 XENAZINE 46 Issues Statement Regarding 46 Receives Positive 46 Emphasizes Need 46 supplemental Biologics License Application 46 CHMP Opinion 46 Investigational Treatment 46 Orphan Drug Designation 46 NAMENDA 46 Cinacalcet HCl 46 Audit Faults 46 assigned PDUFA 46 Million Convertible Debt 46 Amgen Nplate 46 CHMP recommendation 46 Patents Covering 46 Decentralized Procedure 46 VIVUS Announces 46 Somatuline R Autogel R 46 trading symbol GCKO 46 Receives Tentative Approval 46 Shonin approval 46 Supplemental Type 46 Receives Unsolicited 46 Orphan Medicinal Product 46 Generic Version Of 46 Brinavess 46 Extends Term 46 Japanese MHLW 46 Regulatory Clearance 46 Begin Clinical Trials 46 k clearance 46 Pending Merger 46 Announce Successful Completion 46 Rocmec Closes 46 Receives Conditional Approval 46 AFSSAPS 46 Regulatory Approval 46 Prequalified 46 Marketing Authorization Applications 46 blood thinner rivaroxaban 46 Issues Resolved 45 Certican 45 Authorisations 45 FDA Approves 45 Submits Revised 45 Arthritis Drugs 45 Marketing Authorizations 45 Naglazyme R galsulfase 45 Expands Scope 45 Conformite Europeene 45 Receives Stockholder Approval 45 IND Investigational New 45 Unitholders Approve 45 EvaMist NDA submission 45 Remain Listed 45 FIRMAGON R 45 Preliminary Approval 45 Increlex TM 45 granted orphan medicinal 45 Receives Approvals 45 designated Restanza 45 Lorus Therapeutics Announces 45 Marketing Authorization Application 45 RIGScan CR 45 Targretin capsules 45 eCTD format 45 Epilepsy Drug 45 Biologic License Application 45 AVI BioPharma Announces 45 No Objection Letter 45 designated cethromycin 45 Rheumatoid Arthritis Drug 45 TEMODAL 45 Panel Nixes 45 Hyperthermia System 45 Desvenlafaxine Succinate 45 Suit Challenging 45 Administration TGA 45 Orphan designation 45 Patriot Act Provisions 45 drug belatacept 45 Biological License Application 45 Visian Toric ICL 45 Voluntary Delisting 45 SuperStitch ® 45 Arzerra ofatumumab 45 Cervical Cancer Vaccine 45 Regulatory Filing 45 compound CIP FENOFIBRATE 45 Clears Path 45 RP Rating 45 BEMA Granisetron 45 Legislation Introduced 45 Receives Authorization 45 Favorable Decision 45 submit Biologics License 44 Velaglucerase Alfa 44 supplemental biologics 44 Million Milestone Payment 44 Japanese Encephalitis Vaccine 44 PrevOnco ™ 44 Application BLA 44 Panel Endorses 44 Market Authorization Application 44 Proposed Legislation 44 Gets Clearance 44 ZEFTERA ™ 44 ZEGERID Chewable Tablets 44 Surfaxin lucinactant 44 Terminates Contract 44 Genentech Provides Update 44 Amends Stockholder Rights 44 Onrigin 44 Announces Delisting 44 WebTech Wireless Announces 44 Creditor Protection 44 ANVISA 44 Brilique 44 Receives Approval 44 Decentralized Procedure DCP 44 Acquire Controlling Stake 44 Voluntary Withdrawal 44 Would Restrict 44 Gout Drug 44 Listing Approval 44 Gives Thumbs Up 44 Pared Down 44 Waiver Request 44 Weight Loss Drug 44 Metformin GR 44 Impax generic 44 Legislation Passes 44 Reaccreditation 44 Unsolicited Proposal 44 Important Milestone 44 Pirespa 44 Shareholders Approve Plan 44 Stronger Warnings 44 Milestone Payment From 44 Securite Sanitaire des Produits 44 R galsulfase 44 Cloning Ban 44 Stedesa 44 SuperStitch R 44 CIP Fenofibrate 44 Company LUMA imaging 44 Shareholder Vote 44 Reappointments 44 Sertraline Hydrochloride Tablets 44 Theratechnologies Announces 44 Investigational Medicinal Product 44 Approve Proposed 44 y Ambiente SERNA Honduras 44 REMOXY NDA 44 Drug Fails 44 Directors Unanimously Rejects 44 daily Glumetza TM 44 Initiate Phase II 44 Unsolicited Acquisition 44 XIAPEX 44 Monovisc 44 eprodisate KIACTA TM 44 Biologics Licensing 44 Panel Backs 43 Intermezzo ® NDA 43 GRALISE 43 Anti Nausea 43 Junovan 43 Rehearing 43 Approval Process 43 human antithrombin 43 OTC Zegerid 43 KRYSTEXXA TM 43 telavancin NDA 43 ZTEST Announces 43 HPV vaccine GlaxoSmithKline Cervarix 43 TELEC 43 authority Gurian Sherman 43 Schizophrenia Drug 43 Kynapid 43 Formalizes 43 Genetically Modified Salmon 43 pulls Darvon painkiller 43 Amyvid 43 Shareholder Meeting Date 43 Loramyc ™ 43 Whooping Cough Vaccine 43 Bill Clears Hurdle 43 CMDCAS 43 Denies Petition 43 FDA Approves Expanded 43 Gets Thumbs Down 43 testosterone gel LibiGel 43 Paragraph IV certifications 43 Reauthorize 43 Risk Minimization Action 43 Biologics License Application 43 Lupus Drug 43 Drug Approvals 43 Wins Approval 43 CEA Applauds 43 Impax ANDA 43 House Panel Approves 43 Strongly Supports 43 Alvesco R 43 Principle AIP 43 Data Suggest 43 EASA approvals 43 Comment Period 42 Patent Broadly Covering 42 Centralized Procedure 42 Stipulated Order 42 Waiting Period 42 License Renewal 42 FDA Accelerated Approval 42 Synerx 42 FOIA Requests 42 Microcutter 42 Injunction Against 42 granisetron hydrochloride 42 License Application 42 Acetavance TM 42 Temporary Injunction 42 Satellite Radio Merger 42 Plenaxis R 42 ONGLYZA ™ 42 Stock Buyback Plan 42 Holds Hearings 42 BiDil XR 42 Vertex hepatitis C 42 Governor Vetoes 42 Approvable Letter 42 Shingles Vaccine 42 Rasilez HCT 42 Announces Consummation 42 Clears Hurdle 42 Linjeta TM 42 Tentative Approval 42 Concurrence motion 42 Milestone Payments 42 commercialize oritavancin 42 Antitrust Improvement 42 HEPLISAV ™ 42 Continued Listing 42 Considers Extending 42 Blood Pressure Drug 42 DC Bead 42 Confirmatory 42 Megapharm Ltd. 42 ISO Certification 42 Marketing Authorisations 42 Teflaro 42 Sweeping Changes 42 Receives Permit 42 GRAS determination 42 Thelin TM 42 Eliquis 42 Receives Regulatory Approvals 42 Proposed Changes 42 Unanimously Approves 42 Hurdles Loom 42 Panel Advises 42 Abortion Pill 42 Hails Passage 42 Entereg alvimopan 42 Nonproliferation Enhancement Act 42 lender consents 42 MHLW 42 Approvable letter 42 Preliminary plat 42 Fully Subscribed 42 A.#/S.# 42 Unanimous Vote 42 Needs Overhaul 42 Generic Lovenox 42 Groups Applaud 41 Leaders Applaud 41 Panel Rejects 41 Shareholder Approval 41 Reloxin R 41 NASDAQ Delisting Notice 41 Despite Veto Threat 41 Withdraws Application 41 PureGraft 41 sBLA 41 Fast Track designation 41 Dossier IMPD 41 Panel Weighs 41 Enacts 41 Gerdau Ameristeel Announces 41 ISA #.#a standard 41 KYNAPID 41 DIP Loan 41 Proposed Combination 41 Order Authorizing 41 OTC ZEGERID 41 Ceftobiprole 41 Bioresearch Monitoring 41 Votes Unanimously 41 Sepracor insomnia 41 Preliminary Injunction 41 Bidding Procedures 41 Signs Binding Agreement 41 Welfare MHLW 41 Avoid jalapenos 41 Statewide Smoking Ban 41 Regulate Tobacco 41 Antitrust Clearance 41 Share Issuance 41 donepezil hydrochloride 41 APPROVAL 41 Highest Rating 41 Results Confirm 41 Omigard 41 expresses deepest sympathy 41 Winner Notification 41 Approves Merger 41 PUC Approves 41 Temporarily Suspends 41 Panel Approves 41 Lawsuit Filed Over 41 UL Certification 41 Nears Approval 41 CLIA waiver 41 requiring Asthmatx 41 Submits Final 41 INTUNIV TM guanfacine extended 41 Makes Headway 41 Zidovudine Tablets 41 Unanimously Approved 41 CLIA Waiver 41 Pre IND 41 substitutional listing 41 Refile 41 Symbol Symbole 41 Excellent Accreditation status 41 Renegotiates 41 Firazyr 41 Nears Vote 41 Recieves 41 Biotech Firm 41 Proposes Changes 41 OLEPTRO 41 Unanimously Passes 41 Fuwei Films Announces 41 investigator Donna Tartaglino 41 BIO Applauds 41 Terminate Agreement 41 Affirmative Action Ban 41 Ratifies 41 Law Upheld 41 Reorganization Confirmed 41 FDA approvable letter 41 FIPS #-# Certification 41 Cetirizine Hydrochloride Syrup 40 Shareholders Approve Proposed 40 Seeks Input 40 promote ceftobiprole 40 FCC PTCRB 40 OrCel R 40 sNDA filing 40 paliperidone palmitate 40 Waste Discharge 40 Holds Hearing 40 Seeks Tougher 40 Feds Approve 40 IONSYS 40 NESINA 40 Senate Panel Approves 40 Renews Push 40 Arranon 40 GRAS notification 40 Underscores Need 40 Withdraws Request 40 EDQM 40 Clinical Trial Application 40 Receives Permission 40 Modifies 40 Reaches Pact 40 Scrutinizes 40 Decision Delayed 40 Type Approval 40 Orthopedic Advisory Panel 40 Hitachi Fujifilm 40 AAMAC warrantholders 40 Rejects Unsolicited 40 Million Settlement Preliminarily 40 Suit Challenges 40 Imported Drugs 40 Feds Deny 40 Gay Marriage Amendment 40 Cloture Vote 40 Awaits Approval 40 Seeks Approval 40 Enjuvia 40 Swissmedic 40 Novartis AG Galvus 40 ANDA submission 40 Long Awaited 40 Medicinal Products EMEA 40 Regulators Approve 40 Breakup Fee 40 Considers Delaying 40 Merck Arcoxia 40 Unsolicited Tender Offer 40 Terminate Merger 40 InterOil Announces 40 Stockholder Vote 40 Dr. Rafel Rieves 40 gave Makena orphan 40 Resubmit 40 Opposes Proposed 40 Alimta pemetrexed 40 Gets Thumbs Up 40 Acquisition Proposal 40 Viviant 40 Submits 40 Veto Override 40 Rhucin R 40 Sends Warning 40 SLUP 40 Orathecin 40 Overwhelmingly Approve 39 Compromise Reached 39 requisite stockholder 39 Entereg TM 39 Contrave NDA 39 successfully commercialize Silenor 39 Passes Landmark 39 Balance Sheet Restructuring 39 Approval 39 Nebido 39 symbol OCE 39 Q#IR 39 European Medicines Evaluation 39 Reaches Accord 39 Kaletra tablet 39 Approves Dividend 39 RUS Acceptance 39 Designations 39 Moves Forward 39 Propose Changes 39 cSSTI 39 ISO #:# Certification [002] 39 Residency Requirements 39 Averion core competencies 39 APMA Seal 39 Debate Heats Up 39 Moves Towards 39 constitutional amendment disallowing 39 Tablet Formulation 39 Draws Mixed Reactions 39 Preemption 39 Emisphere Technologies Announces 39 Voraxaze 39 BLA filing 39 Reiterates Support 39 Abortion Restrictions 39 Secretaria de Recursos Naturales 39 Extending Unemployment Benefits 39 Hits Speed Bump 39 PillCam Colon 39 Issues Reminder 39 Eucreas 39 Lacks Votes 39 Clearford Announces 39 Narrowly Passes 39 Rejects Request 39 self affirmed GRAS 39 Rhucin ® 39 Advisers Urge 39 Considers Changing 39 Files Petition 39 Gets Tentative 39 Drilling Permit 39 Files Complaint Over 39 transfusional iron overload 39 Pfizer maraviroc 39 Gestiva 39 Comair Pilots 39 Qinnan Production Sharing Contract 39 pediatric exclusivity 39 Drug Application 39 Tentatively Approves 39 Priority Review 39 IND submission 38 Panel Recommends 38 Temporary Waiver 38 use authorization EUA 38 Mylan ANDA 38 orphan drug 38 symbol FGT 38 Xifaxan rifaximin 38 Ondansetron Injection 38 Contract Renewal 38 Panel Votes 38 Override Veto 38 Elonva 38 Adenuric 38 Biotech Crops 38 Groups Oppose 38 APF# NDA 38 CHMP opinion 38 Ownership Rules 38 Passes Milestone 38 Approves Revised 38 cusip number 38 Overwhelming Response 38 orally bioavailable compound 38 Readied 38 Cloned Meat 38 Immigration Overhaul 38 Reach Tentative Contract 38 FDA Psychopharmacologic Drugs 38 Whitewash Waiver 38 pertussis Tdap vaccine 38 Rulemaking 38 Judicial Nominee 38 Patanase 38 Approves 38 lorcaserin NDA 38 Administration PHMSA 38 Settle Dispute Over 38 Panel Upholds 38 Adolf Hitler dictatorial 38 Gets Approval 38 Wood Preservative 38 Senators Propose 38 Lawmakers Propose 38 ADDERALL XR R 38 subsidiary Glenmark Generics 38 Sirius XM Merger 38 Prohibit targeting foreigner 38 daily bactericidal antibiotic 38 Strikes Down 38 Seeks Clarification 38 Debate Rages 38 alogliptin NDA 38 Jobless Benefits 38 Evoltra TM 38 MethyPatch 38 NDA BLA 38 Lorqess 38 CoPP 38 Gets Mixed Reviews 37 Brownfield Cleanup 37 Wants Stricter 37 Faces Obstacles 37 disinterested shareholder 37 Clears Way 37 Temporary Closure 37 Regulatory Overhaul 37 Court Annuls 37 Reaffirms Support 37 Meloxicam Tablets 37 Ballot Count 37 Rejects Effort 37 Vimovo 37 ReCell 37 Invalidate 37 eg NDA BLA 37 Approves Controversial 37 # Approving 37 Unanimous Approval 37 Taxol r 37 Overrules 37 Denies Request 37 Metformin Hydrochloride 37 Frequency Allocation 37 silicone gel filled 37 XXX Domain 37 Approved 37 Hits Roadblock 37 Sets Tentative 37 Lawsuit Settlement 37 Drilling Permits 37 Omapro 37 R sipuleucel T 37 Binding Offer 37 taliglucerase alfa 37 Fluviral 37 Status Passed 37 Hotly Debated 37 Use Commendation 37 Re Examine 37 Swine Flu Vaccines 37 Seek Input 37 securityholder approvals 37 Zolpidem Tartrate Tablets 37 Seeks Buyer 37 Referendum Petition 37 Clolar 37 Nadcap accreditation 37 Patent Term 37 Regain Compliance With 37 Zanaflex Capsules competition 37 Proposed Reorganization 37 Antitrust Immunity 37 liprotamase 37 Drill Permit 37 Mad Cow Testing 37 KEDFA 37 Egrifta 37 Approves Sale 37 Effort Fails 37 securityholder approval 37 approvable letters 37 requisite consents 37 GMP Certification 37 Rejects Proposed 37 Temporary Reprieve 37 Optaflu 37 CE Conformité Européenne 37 Panel Urges 37 Public Utilities DPU 37 Deadline Approaches 37 Faces Uncertain 37 Negotiations Continue 37 spokeswoman Lenore Gelb 37 Qinnan PSC 37 Eases Rules 37 customary regulatory approvals 36 Hiberix 36 Damages Claim 36 Court Overrules 36 Apablaza extradition 36 Company Skouries Olympias 36 Exelbine NDA 36 Dealt Setback 36 Minimum Wage Increase 36 Rezoning Request 36 HPV vaccine Cervarix 36 & Workover Fluids 36 CUSF application 36 Schematic Design 36 OFIRMEV TM 36 Google Permissions 36 Restricts Access 36 consents authorizations 36 PROLACRIA ™ 36 EGRIFTA ™ 36 Veto Threat 36 Novartis Gilenia 36 Takeover Bids 36 Authorization 36 Showdown Looms 36 trans Atlantic antitrust immunity 36 Orexigen Contrave 36 Postpones Decision 36 Deadline Arrives 36 #B Bailout 36 CPCN 36 Lilly Effient 36 Jobless Benefits Extension 36 Special Exception 36 Lawmakers Approve 36 Leans Toward 36 Urges Rejection 36 Abandons Plans 36 BPZ Energy Announces 36 Reorganization Plan 36 generic Zithromax 36 Same Sex Benefits 36 Blackout Probe 36 Senators Criticize 36 Close Loopholes 36 LSE PFZ 36 Considers Expanding 36 Phasing Out 36 From Cloned Animals 36 Irinotecan Hydrochloride Injection 36 GRAS status 36 Delist 36 Combined License Application 36 Higher Doses 36 mutually satisfactory definitive 36 Approves Settlement 36 Preliminary Plat 36 generic enoxaparin sodium 36 Nears Completion 36 Competitive Bids 36 Generous Donation 36 ANDAs abbreviated 36 Therapeutic Goods Administration TGA 36 Postpones Vote 36 Bln Deal 36 Wrangle Over 36 pixantrone NDA 36 ACCCE Statement Regarding 36 PDUFA reauthorization 36 Urges Compromise 36 Increased Scrutiny 36 Cash Infusion 36 FDA Antiviral Drugs 36 Glaxo Cervarix 36 China Phytase corn 36 Passes Legislation 36 Extends Deadline 36 Gives Thumbs Down 36 Proquin 36 Stirs Debate 36 ISO TS #:# certification 36 Sweetened Offer 36 Hearings Continue 36 Poll Shows Support 36 Be Studied 36 Conditionally 36 Adjourns 35 Prospects Dim 35 First Step Toward 35 Delays Vote 35 Merger Proposal 35 Moves Ahead 35 Categorical Exclusion 35 Therapeutic Products 35 EMPOWER Study 35 Reconvene 35 Hold Hearings 35 USFDA approval 35 Palin Alaska Gasline 35 Nuke Waste 35 Lawmakers Oppose 35 Zensana 35 Greenhouse Gas Emissions Trading 35 WHO prequalification 35 clearance eg probenecid 35 Reject Proposed 35 Disinterested shareholders 35 Buyback Plan 35 Lays Out Plan 35 drug Mylotarg 35 conditionally approves 35 AstraZeneca Seroquel XR 35 postmarket studies 35 Deeply Disappointed 35 Finds Problems 35 Tentative Deal Reached 35 Gets Nod From 35 Non Binding 35 Antitrust Approval 35 Revokes 35 Provenge prostate cancer 35 Gives Nod 35 Bipartisan Support 35 Failing Grades 35 prefiling 35 To Decide Fate 35 Authorizes 35 Authorizations 35 DATES Comments 35 Would Violate 35 vernakalant IV 35 Noriega Extradition 35 GCF certification 35 Sipex stockholders 35 Reneges 35 Fampridine SR Acorda Therapeutics 35 Appeal Ruling 35 provisional accreditation 35 PSF guaranty 35 biosimilar filgrastim 35 ANDA abbreviated 35 Misses Deadline 35 NCL PMD 35 reauthorisation 35 Ease Restrictions 35 Exploitation Concession